Company Executives

$ Management Team

Ms. Kat Lange

Chief Business Officer

Age -

Compensation -

Sex Female

Mr. John McKenna

President

Age -

Compensation -

Sex Male

Mr. Eduard Marti

Treasurer

Director

Age -

Compensation -

Sex Male

Mr. Jamie Huertas

Secretary

Director

Age -

Compensation -

Sex Male

Name / Title	Age	Compensation	Sex
Ms. Kat Lange Chief Business Officer	-	-	Female
Mr. John McKenna President	-	-	Male
Mr. Eduard Marti Treasurer Director	-	-	Male
Mr. Jamie Huertas Secretary Director	-	-	Male

Board of Directors

From the proxy statement filed Apr 29, 2025

Directors

serving now

Independent

7 of 9

stated in the proxy

Average tenure

5.2 years

from year joined

CEO also chairs the board

Troy Wilson

Director	Age	On board	Independent	Committees	Other public boards	2024 pay
Arthur A. Levin	Not stated	2023 2 years	Not independent	None stated	Stoke Therapeutics, Inc.	Not stated
Simona Skerjanec	Not stated	2024 1 year	Independent	None stated	Immunic Therapeutics	$880,814
Tamar Thompson	Not stated	2021 4 years	Independent	Human Capital Management Nominating and Corporate Governance	Catalyst Pharmaceuticals, Inc.	$423,989
Carsten Boess	Not stated	2020 5 years	Independent	Audit · Chair	Rocket Pharmaceuticals, Inc., Achilles Therapeutics plc	$429,989
Sarah Boyce CEO	Not stated	2019 6 years	Not independent	None stated	Contineum Therapeutics, Inc.	Paid as CEO
Troy Wilson Board chair	Not stated	2012 13 years	Independent	Human Capital Management	Kura Oncology, Inc., Puma Biotechnology, Inc.	Not stated
Noreen Henig	Not stated	2019 6 years	Independent	Audit	None stated	$430,489
Edward M. Kaye	Not stated	2019 6 years	Independent	Nominating and Corporate Governance	Stoke Therapeutics Inc., Cytokinetics, Inc.	$428,989
Jean Kim	Not stated	2021 4 years	Independent	Audit	None stated	$422,489

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 29, 2025 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$ Management Team

Ms. Kat Lange

Mr. John McKenna

Mr. Eduard Marti

Mr. Jamie Huertas

Board of Directors

Related-party transactions

No related-party transactions disclosed